News Focus
News Focus
icon url

EyeamBill

09/16/10 12:30 PM

#104396 RE: pollyvonwog #104394

Let's Try The MNTA P/E Question This Way

Imagine that you're not following MNTA and you're going to a stock screener. One of the criteria that you want to search for, within the biotech industry is the P/E ratio, either trailing or forward.

What number would you put in that screener to capture the best of breed while presumably excluding the risker overpriced biotech companies?

I understand this is a futile exercise for those who follow MNTA closely. I'm just trying to gauge what the masses might use who don't follow it at all.

Since such a large percentage of MNTA is held by institutions it might be argued that the masses won't have much of an effect, so why bother? But, remember that on the ticker it is only the last trade that is posted, regardless who makes it.

Bill
icon url

wallstarb

09/16/10 12:31 PM

#104397 RE: pollyvonwog #104394

For the sake of not having to be bothered with more inane questions and challenges to the obvious - I decided to change my opinuion and now I believe MNTA will be the only company to ever have an approved generic version of lovenox and it should trade at $100

Thanks